Epidemiology, Treatment and Prognosis of Neonatal Meningitis in Turkey: A Multicenter Study
NCT ID: NCT04009551
Last Updated: 2019-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2019-06-01
2019-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objectives of this study were to assess the incidence, temporal trend, risk factors, causative organisms, and short term outcomes of neonatal meningitis in a large national cohort of newborn infants admitted to Turkey NICUs.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
New Protocol for Febrile Neonate Management
NCT03183531
Evaluation of Newborns Presenting With Suspected COVID 19
NCT04519307
Neonatal Bacterial Meningitis Cohort
NCT03499652
Evaluation of the Levels of Calcitonin Gene-related Peptide and Substance P
NCT06510751
Febrile Infant Diagnostic Assessment and Outcome Study
NCT05259683
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has a positive blood culture of bacterial pathogen and counts of white blood cells in cerebrospinal fluid ≥20 /mm3.
Exclusion Criteria
* Cultures positive for coagulase-negative staphylococci (CONS) were excluded as possible contaminants, if not clinically and laboratory compatible with meningitis.
30 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zekai Tahir Burak Women's Health Research and Education Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehmet Yekta Oncel
Head of Neonatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehmet Yekta Oncel, M.D.
Role: PRINCIPAL_INVESTIGATOR
Tepecik Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zekai Tahir Burak Women's Health Research and Education Hospital
Ankara, , Turkey (Türkiye)
Bursa Yuksek Ihtisas Research and Education Hospital
Bursa, , Turkey (Türkiye)
Gazi Yasargil Education Research Hospital
Diyarbakır, , Turkey (Türkiye)
İstanbul Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Izmir Katip Celebi University, Medical Faculty
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Tepecik35
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.